SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to widespread app outages, reportedly linked to Amazon Web Services, leaving users unable to access their accounts and sparking frustration. The community is expressing concerns about the platform's reliability and potential legal action, while some speculate about market manipulation. Despite the issues, the stock is showing resilience, leading to discussions about its future and potential decoupling from platform performance.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amidst community discussions around its potential for another short squeeze, drawing comparisons to the $BYND surge and past events with $AMC. Investors are closely monitoring utilization rates and options activity, while also debating the impact of Ryan Cohen's recent commentary and future company strategy. Overall sentiment is mixed, with some expressing frustration while others remain optimistic about a potential breakout.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors digest news of OpenAI launching a web browser, sparking concerns about potential competition with Google Chrome. The community is actively discussing the implications of this development on Google's search dominance and advertising revenue, while also weighing Alphabet's investments in AI and cloud infrastructure. Some are viewing the dip as a buying opportunity, while others are remaining cautious amid the evolving AI landscape.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending following strong earnings and procedure growth, particularly with the da Vinci 5 system. The community is weighing the impact of tariffs and margin pressures against the company's long-term growth potential and market dominance in robotic surgery. Bullish sentiment is fueled by raised guidance and analysts' price targets, while some caution against high valuation and potential market volatility.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending due to a mixed Q3 earnings report and cautious forward guidance, sparking concerns about the near-term outlook despite a strong analog chip performance. Community discussions center on whether this drop represents a buying opportunity or signals deeper industry headwinds, with some analysts questioning the capital expenditure plan. Investors are also monitoring tariff implications and potential shifts in market share amid evolving US-China trade dynamics.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to a recent $1 billion capital raise via a convertible note offering, sparking discussions about dilution and the company's financial strategy. While some investors express concerns about potential dilution, others view the raise as a bullish move to fund satellite constellation deployment and secure long-term growth. The community is actively analyzing the offering's terms and speculating on upcoming catalysts, including potential partnerships and launch milestones.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending following the announcement of its acquisition of Railbird, signaling a move into prediction markets beyond sports betting, with the launch of DraftKings Predictions. Community discussions revolve around whether this strategic shift will drive growth or if DraftKings is late to the game, while also debating its impact on existing sports betting licenses and competition with prediction market platforms.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the tokenization of Satoshi Nakamoto's legacy, emphasizing its potential to become a leading meme coin. Community members express strong conviction in its long-term relevance and significant growth potential within the crypto space. The discussion highlights the narrative's alignment with the ethos of decentralization and its symbolic value in the broader cryptocurrency movement.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending amid discussions about AI competition and its potential impact on Google's search dominance, with investors weighing the implications of new AI browser technologies. Community members are also focused on Google's AI investments and potential partnerships, particularly regarding its cloud infrastructure and Gemini AI model. Positive analyst ratings and potential earnings run-ups are contributing to the stock's current momentum.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending following news of a $200M financing deal to advance its schizophrenia treatment, potentially a major catalyst. Community discussions highlight the stock's low float and potential for significant gains, with some drawing comparisons to previous high-flying stocks and anticipating a continued run.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hillenbrand (HI) announced on Wednesday that it has entered into a definitive agreement to be acquired by an affiliate of Lone Star Funds in an all-cash transaction valuing the company at $3.8 billion.Shares of Hillenbrand jumped nearly 19% in premarket trading after the company said it would be bought for $32.00 per share, which represents a premium of approximately 37% over Hillenbrand's unaffected closing share price of $23.43 on August 12. The transaction is expected to close by the end of the first quarter of calendar year 2026.Retail sentiment on <a href="https://stocktwits.com/symbol/HI">Hillenbrand</a> improved to ‘neutral’ from ‘bearish’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits.&nbsp;“The Board carefully reviewed a range of potential strategic alternatives, including interest from a number of parties, and determined that this transaction is in the best interest of Hillenbrand and its shareholders,” said Helen Cornell, Chairperson of the Board of Directors.Hillenbrand said that once the deal is closed, it will become a privately held company, and the company’s shares will no longer trade on the New York Stock Exchange. Shares of the company traded nearly 3% higher in Wednesday’s pre-market session.The company said during its fourth-quarter results that it would not be issuing financial guidance for fiscal year 2026.Hillenbrand is known for providing processing equipment and solutions to customers around the world through its Advanced Process Solutions and Molding Technology Solutions segments.&nbsp;Shares of Hillenbrand have declined nearly 14% this year and have fallen 6% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-dollar-tree-stock-rising-today/ch6nw5IR3NW">Why Is Dollar Tree Stock Rising Today?</a>

Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds

The company will be bought for $32.00 per share, which represents a premium of approximately 37% over Hillenbrand's unaffected closing share price on August 12.

Equity

AST SpaceMobile (ASTS) shares hit an all-time high of $98.59 on Tuesday, and the stock was the top trending ticker on Stocktwits, building on the momentum following its partnership with Verizon to support space-based cellular broadband across the United States.The retail user message count on <a href="https://stocktwits.com/symbol/ASTS">AST SpaceMobile</a> increased by over 200% over 24 hours on Stocktwits, as of Tuesday morning. Retail sentiment on the stock remained unchanged in the ‘extremely bullish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.A bullish user on Stocktwits believes that AST SpaceMobile stock will reach $150 next year.<stembedurl>https://stocktwits.com/V792/message/632280773</stembedurl>Last week, the company noted that the agreement with Verizon is to provide direct-to-cellular AST SpaceMobile service when needed for Verizon customers starting in 2026.AST SpaceMobile has deployed the most expansive commercial communications arrays in low Earth orbit, enabling direct connectivity to standard smartphones without requiring specialized hardware.The company’s network is designed to operate across premium low-band spectrum, the company's own licensed L-band and S-band spectrum, and up to 1,150 MHz of mobile network operator partners' low- and mid-band spectrum, globally. These capabilities advance AST SpaceMobile's efforts toward commercial service.&nbsp;“The agreement will extend the scope of Verizon’s 850 MHz premium low-band spectrum into areas of the U.S. that would benefit from the ubiquitous reach of space-based broadband technology,” said Abel Avellan, Founder and CEO of AST SpaceMobileAnother bullish user on Stocktwits expects the stock to hit $100 by the close of trading on Tuesday.<stembedurl>https://stocktwits.com/pathforward/message/632277086</stembedurl>Shares of AST SpaceMobile have jumped 357% this year and gained over 297% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dominos-cfo-sees-early-q4-weakness-across-us-restaurant-industry/ch6mwQqR3ZT">Domino’s CFO Sees Early Q4 Weakness Across US Restaurant Industry</a>

In this photo illustration the AST SpaceMobile logo is seen on a smartphone and a pc screen. 

ASTS Stock Hit Fresh All-Time Highs Today: What’s Driving The Investor Buzz?

The retail user message count on AST SpaceMobile increased by over 200% over 24 hours on Stocktwits, as of Tuesday morning, while retail sentiment on the stock remained unchanged in the ‘extremely bullish’ territory.

Humana (HUM) has reportedly lost a lawsuit seeking to undo cuts to the bonus payments it receives from the federal Medicare insurance program.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-14/humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts">reported</a> on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage. The judge had <a href="https://stocktwits.com/news-articles/markets/equity/humana-loses-lawsuit-over-medicare-bonus-cuts-stock-slides/ch8ks9QR5q8">dismissed</a> a similar case in July as well.Humana depends more than any other large insurer on revenue from the Medicare Advantage program, Bloomberg noted. About $3 billion was at stake in the lawsuit, the report said, citing consulting firm Capstone.Centers for Medicare &amp; Medicaid Services (CMS) assigns quality ratings, called stars, to Medicare Advantage plans, ranging from one to five, with five being the highest rating. Beneficiaries can use this data to help choose plans, and insurance companies can receive government bonus payments for higher ratings.Humana’s stock dropped as much as 4% at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HUM">HUM stock</a> stayed within the ‘bearish’ territory, coupled with ‘low’ message volume.<figure class="image"><img style="aspect-ratio:588/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_12_53_12_PM_png_e17a866cd8.webp" alt="HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits" width="588" height="62"><figcaption>HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits</figcaption></figure>Earlier this month, Humana <a href="https://stocktwits.com/news-articles/markets/equity/humana-stock-rises-after-insurer-reaffirms-full-year-earnings-guidance/chCrmVZR3fE">affirmed</a> its full-year earnings per share guidance provided in July.The insurer stated that it expects adjusted earnings per common share of $17 for the year ending Dec. 31, 2025, and diluted earnings per share of $13.77.The firm also stated that its preliminary 2026 Medicare Advantage (MA) Star Ratings align with the assumptions in its financial planning. As a result, there is no change to the incremental earnings potential for 2025 to 2028. The ratings data provided by the Centers for Medicare &amp; Medicaid Services was inadvertently accessible on CMS Plan Finder for a brief period on Oct. 1, 2025, the company stated.Humana has about 20% of its members currently enrolled in Medicare plans rated four stars and above for 2026, and 14% of members in 4.5-star plans for 2026, it said.“Based on all information available to date, the company remains confident in its 2026 Individual MA pricing and benefit design, including the expectation that it will double individual MA pre-tax margin in 2026 (excluding Stars), and believes it is positioned to return to membership growth in 2026,” the firm said.HUM stock rose 3% this year and fell about 2% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novavax-major-shareholder-calls-for-sale-of-company-to-larger-pharma-entity/ch6moRsR3mh">Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The MyHumana app page is displayed on a smartphone in the Apple App Store in front of the Humana Inc logo on October 30, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)

Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments

Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.

Planet Labs (PL) is reportedly set to deploy a new constellation of Earth observation satellites, which are designed to deliver high-resolution, AI-enhanced imagery within an hour.According to a Bloomberg News <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-08/planet-labs-to-launch-satellites-promising-images-in-an-hour?srnd=homepage-americas">report</a>, the newly introduced monitors, known as Owl, will bolster Planet Labs’ current fleet of approximately 150 imagery spacecraft in orbit. The report added that these systems are designed to monitor changes, from natural disaster impacts to the movement of vessels and aircraft.Planet Labs is looking to build and launch nearly 40 Owl satellites in the coming few years, with the initial test launch for these slated towards late 2026, Chief Executive Officer Will Marshall told Bloomberg in an interview.“Looking at the nature of modern war situations from Israel in the Middle East to Ukraine, people have seen that satellites and drones are critical to information advantage, which in turn is critical to their security,” Marshall said, according to the report.Retail sentiment on <a href="https://stocktwits.com/symbol/PL">Planet Labs</a> remained unchanged in the ‘bullish’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits. Shares of the company were up 1% in early trading.The report added that Nvidia Corp’s (NVDA) chips will be used in these Owl satellites and will help in using artificial intelligence to search and identify events on Earth quickly. Bloomberg noted that the company said this was to ensure that customers can make real-time decisions in case of disaster relief, intelligence gathering and military responses.Shares of Planet Labs have gained 638% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="http://stocktwits.com/news-articles/markets/equity/best-buy-shares-jump-2-as-jefferies-sees-advertising-boosting-margins/ch6EZaGR3in">Best Buy Shares Jump 2% As Jefferies Sees Advertising Boosting Margins</a>

In this photo illustration, a smartphone held in a hand shows the logo of Planet Labs PBC

Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report

According to a Bloomberg News report, the newly introduced monitors, known as Owl, will bolster Planet Labs’ current fleet of approximately 150 imagery spacecraft in orbit.

Plug Power (PLUG) announced on Tuesday that it has appointed insider Jose Luis Crespo as its new Chief Executive Officer, succeeding long-time head Andy Marsh.&nbsp; Shares of the company fell over 1% at the opening bell.The company stated that Marsh will continue to serve as CEO during the transition period and has been appointed executive chair of the board, a position he will retain after March 2, 2026. In conjunction, George McNamee has been named Lead Director, and the company said that both Board appointments are effective Oct. 10, 2025.The appointment of Crespo is to be effective as of the date the company files its annual report for the year ended Dec. 31, 2025. This is expected in March 2026.&nbsp;“My focus will be on execution, profitability, and customer success, ensuring that Plug continues to convert its technology leadership into sustainable growth,” Crespo said.Retail sentiment on <a href="https://stocktwits.com/symbol/PLUG">Plug Power</a> improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.Crespo joined&nbsp;Plug Power in 2014 and most recently served as Chief Revenue Officer. The company stated that, in his roles with the firm for more than a decade, Crespo has played a pivotal role in Plug’s growth, serving as the primary architect of a sales funnel that has generated over $8 billion in transformational opportunities.&nbsp;Plug also said that Crespo has been instrumental in strengthening relationships with key customers such as Amazon, Walmart, and Home Depot, while driving hydrogen adoption programs.Plug Power stock has rallied 76% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/applovin-rises-5-premarket-after-citigroup-recommends-buying-the-stock/ch6PfUIR3hP">AppLovin Rises 5% Premarket After Citigroup Recommends Buying The Stock Amid SEC Investigation Concerns</a>

Plug Power Names Insider Jose Luis Crespo As New CEO

Plug Power said that current CEO Andy Marsh will continue to serve in his position during the transition period and has been appointed executive chair of the board, a position he will retain following March 2, 2026. 

UnitedHealth Group’s (UNH) shareholder Accountability Board has reportedly filed a proposal seeking an independent chairman of the board, separate from the CEO.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-03/unitedhealth-shareholder-wants-chairman-and-ceo-roles-separated">reported</a> on Friday that the nonprofit advocacy group’s proposal, if approved by shareholders, would ask the board to amend the company’s bylaws to codify an independent board chair. Currently, Stephen Hemsley serves as both CEO and chair of the board.“We were very disturbed to see recently that at such a trying time for UnitedHealth, the company chose to go backward and combine the CEO and chair roles,” Accountability Board President Matt Prescott said, as reported by Bloomberg. Prescott also called for a stronger leadership structure at the insurer while declining to disclose the size of the group’s stake in UNH, the report said. However, he noted that the stake meets the minimum requirement to file a shareholder proposal.The report noted that it is unclear whether the Accountability Board’s resolution will proceed to a shareholder vote.Shares of UNH traded 3% higher at the time of writing. On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> remained within the ‘bearish’ territory, while message volume remained at ‘low’ levels.Hemsley has been chairman of the company’s Board of Directors since 2017. Before that, he also served as CEO. He was reappointed as CEO in May when Witty <a href="https://stocktwits.com/news-articles/markets/equity/unitedhealth-suspends-2025-guidance-ceo-andrew-witty-resigns/chi8S4qRbZQ">stepped down</a>, citing personal reasons, but while retaining his chair position. This is contradictory to UnitedHealth’s principle of governance, which also calls for separate roles, Bloomberg noted.The insurer issued <a href="https://stocktwits.com/news-articles/markets/equity/united-health-price-target-lowered-by-bernstein-after-soft-guidance-but-retail-hopes-for-long-term-recovery/chrXElQRdRK">fresh guidance</a> of full-year revenue of $445.5 billion to $448.0 billion and adjusted earnings of at least $16.00 per share in July after suspending its previous outlook in May, citing higher medical costs. The company had previously forecast adjusted profit of $29.50 to $30.00 per share, nearly double its latest forecast. The company also <a href="https://stocktwits.com/news-articles/markets/equity/united-health-s-cfo-shake-up-doesn-t-deter-retail-bulls-traders-call-stock-a-2018-level-opportunity/chr3k1VRdGi">appointed</a> Wayne S. DeVeydt as CFO in July, replacing John F.Rex.UNH stock is down 28% this year and approximately 39% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-gets-price-target-hike-from-jpmorgan-after-q3-deliveries-beat-estimates/chCumk4R3QJ">Tesla Gets A Price Target Hike From JPMorgan After Q3 Deliveries Beat Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report

Stephen Hemsley currently serves as both CEO and Chairman of the Board.

Anavex Life Sciences (AVXL) on Thursday said that its investigational drug achieved its primary endpoint in a mid-stage trial and demonstrated safety and tolerability in adults with Schizophrenia.Shares of the company soared 9% in Thursday’s pre-market session.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/02/3160275/29248/en/Anavex-Life-Sciences-Announces-Positive-Topline-Results-from-Phase-2-Study-of-ANAVEX-3-71-for-the-Treatment-of-Schizophrenia.html">said</a> that the safety profile of ANAVEX3-71 was consistent with previous studies in healthy volunteers, and no serious treatment-emergent adverse events were reported in the study.The company is evaluating the drug in the treatment of Schizophrenia, a persistent and often disabling mental illness impacting how a person thinks, feels, and behaves, and affects nearly 24 million people worldwide. According to Anavex, the illness impacts 2.8 million people in the U.S. alone.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AVXL">AVXL stock</a> jumped from ‘neutral’ to ‘bullish’ over the past 24 hours, while message volume stayed at ‘high’ levels.Anavex also said on Thursday that encouraging trends were observed in biomarkers of Schizophrenia in the study that support continued development. This includes a reduced glial fibrillary acidic protein in patients receiving ANAVEX3-71 compared to placebo.GFAP is a marker of neuroinflammation, and a reduction in it suggests a potential disease-modifying effect that may become more pronounced with longer treatment durations, the company said.The company on Thursday also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/02/3160281/29248/en/Anavex-Life-Sciences-Announces-Successful-Development-of-Once-Daily-Oral-Tablet-Formulation-for-the-ANAVEX-3-71-Program.html">announced</a> the successful development of a once-daily oral tablet formulation for the ANAVEX3-71 program. The tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling once-daily dosing, it added.AVXL stock is down 16% this year but up approximately 59% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rivian-slashes-full-year-delivery-guidance-after-drop-in-q3-figures/chCrfpbR3OH">Rivian Slashes Full-Year Delivery Guidance After Drop In Q3 Figures</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update

The company said that its investigational drug for Schizophrenia achieved its primary endpoint in a mid-stage trial.

Amgen (AMGN) on Friday announced a $650 million expansion of its U.S. manufacturing network, on the heels of President Trump’s latest pharmaceutical tariff announcement.Trump said in a post on Truth Social on Thursday that the United States will impose a 100% tariff on branded and patented pharmaceutical products starting October 1 unless manufacturers are actively building plants in the country.Amgen <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.amgen.com/newsroom/press-releases/2025/09/amgen-announces-650m-expansion-of-us-manufacturing-creating-hundreds-of-new-jobs">said</a> on Friday that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico. The investment is also expected to create about 750 jobs, including construction roles and skilled manufacturing jobs. According to Amgen, the company has invested more than $40 billion in U.S. manufacturing and research and development since late 2017.Earlier this year, the company announced a $900 million expansion of its Ohio manufacturing facility, which followed a late-2024 announcement of a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AMGN">AMGN stock</a> fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:622/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_26_at_1_54_57_PM_png_99b99c433b.webp" alt="AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits" width="622" height="62"><figcaption>AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits</figcaption></figure>Jefferies analyst Akash Tewari stated on Friday that Trump’s tariffs may not have a material impact on pharmaceutical companies, as several large-cap pharmaceutical firms have already announced plans to establish U.S. manufacturing facilities.A Stocktwits user echoed the analyst’s sentiment, stating that Amgen will also likely be unaffected by the tariffs.<stembedurl>https://stocktwits.com/BobBijawklah/message/630132763</stembedurl>AMGN stock is up 4% this year and down by about 15% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bioaffinity-technologies-stock-surge-over-cypath-lung-case-studies/chDVjeMR3ea">bioAffinity Technologies Stock Surged A Whopping 79% Today – Here’s An Important Update</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company logo and the lettering of the biotechnology company Amgen can be seen on the facade of the company's headquarters in Munich (Bavaria) on January 14, 2025. Photo: Matthias Balk/dpa (Photo by Matthias Balk/picture alliance via Getty Images)

Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement

Amgen said that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico.

Uber Technologies (UBER) reportedly expects faster-than-expected growth for its grocery and retail delivery segment. &nbsp;Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-26/uber-sees-non-takeout-deliveries-becoming-12-5-billion-business?srnd=homepage-americas">reported</a> on Friday, citing a company spokesperson, that Uber expects non-restaurant deliveries to hit an annual run rate of $12.5 billion in gross bookings by the end of 2025. This marks a growth of over 25% from the $10 billion run rate the company shared earlier this year in May, the report added. &nbsp;<a href="https://stocktwits.com/symbol/UBER">UBER shares</a> traded flat at the time of writing. On Stocktwits, retail sentiment regarding UBER stock shifted from ‘neutral’ to ‘bearish’ territory over the past 24 hours.In the second quarter, Uber’s delivery segment saw a 20% increase in gross bookings to $21.7 billion, while revenue jumped 25% to $4.1 billion. In fact, in the second quarter, the delivery segment accounted for nearly half of the company’s gross bookings.However, CEO Dara Khosrowshahi said in August that Uber still has “a long runway to drive further adoption” in delivery, noting that 75% of its rideshare customers have not tried ordering grocery and retail goods from the Uber app, as reported by Bloomberg.Rebecca Payne, group product manager for grocery and retail, told Bloomberg that 6 p.m. on Sundays is the peak time for grocery orders on Uber, and the most popular items are bananas, limes, lemons, cucumbers, Hass avocados, and red Roma tomatoes. More updates about the business are expected at the annual Groceryshop conference in Las Vegas on Sunday, the report added.In the past few months, Uber has announced partnerships or collaborations with multiple names in the grocery and retail sectors, including grocer ALDI, electronics company Best Buy, beauty retailer Sephora, and even Dollar Tree.Earlier this week, the company also announced weekly offers on groceries through the Fresh Days program, which is available to customers in the U.S., Canada, the U.K., South Africa, France, Japan, Taiwan, and Spain. For Fresh Days in the U.S., Uber One members will get 30% off every Tuesday on select fresh produce, meats, dairy, and eggs.Uber stock is up 62% this year and approximately 27% over the past 12 months.&nbsp;Get updates to this developing story <a href="https://stocktwits.com/news-articles/markets/equity/uber-reportedly-expects-non-restaurant-deliveries-to-surge-faster-than-previously-expected/chDVlUmR3eW">directly on Stocktwits.</a>

An Uber Eats courier rides a bicycle through the streets of Amsterdam, Netherlands, on September 10, 2025. The rider carries a large green delivery bag. (Photo by Michael Nguyen/NurPhoto via Getty Images)

Uber Reportedly Expects Non-Restaurant Deliveries To Surge Faster Than Previously Expected

Bloomberg reported on Friday, citing a company spokesperson, that Uber expects grocery and retail deliveries to hit an annual run rate of $12.5 billion in gross bookings by the end of 2025.

Activist hedge fund Engine Capital is reportedly pushing Acadia Healthcare (ACHC) to refresh its board as it faces multiple federal investigations.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/e96d221b-c275-4b3e-86aa-250f784d55dc">report</a> by The Financial Times, the fund holds a roughly 3% stake in Acadia and has written a letter to the company's board, requesting a review of its asset portfolio, improvements to its board of directors, and the halting of capital-intensive projects for new facilities.Acadia provides for-profit behavioral healthcare services. It is currently facing probes from the Department of Justice and Securities and Exchange Commission over allegations of holding patients against their will and falsifying insurance claims, the report noted.Shares of the company rose over 8% on Wednesday morning following the news. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ACHC">ACHC</a> stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.Tennessee-headquartered Acadia operated a network of 274 behavioral healthcare facilities, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics, with approximately 12,100 beds in 39 states and Puerto Rico as of the end of June. The company estimates that it serves more than 82,000 patients daily.As per FT, Engine Capital accused Acadia of maintaining a “growth at any cost” approach in its letter. It alleged that the approach has given rise to a bloated corporate structure and noted that a 2022 reorganisation left the company with an unwieldy management structure that has stifled the company’s turnaround.The firm also urged the company to add new directors with experience in behavioral health and capital allocation, while noting that the current board has no director with relevant operating experience. The hedge fund also encouraged the company to consider selling its assets and repurchasing shares.ACHC stock is down 40% this year and approximately 69% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uniqure-stock-rises-pre-market-after-investigational-huntingtons-disease-drug-slows-disease-in-trial/chD1GAOR33X">uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration an Acadia Healthcare logo is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Acadia Healthcare Stock Surges After Activist Hedge Fund Reportedly Seeks Board Revamp

According to a report by The Financial Times, the fund has written a letter to the company's board, requesting a review of its asset portfolio and improvements to its board.

According to a report by The Financial Times, the fund holds a roughly 3% stake in Acadia and has written a letter to the company's board, requesting a review of its asset portfolio, improvements to its board, and the halting of capital-intensive projects for new facilities.

iShares Trust - iShares ESG Aware 60/40 Balanced Allocation ETF

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

EAOR
iShares ESG Aware 60/40 Balanced Allocation ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EAOR News

EAORiShares ESG Aware 60/40 Balanced Allocation ETF